Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 4.60bn | 3.33bn | 3.10bn | 2.89bn | 926m | 1.11bn |
| Cost of revenue | 2.78bn | 1.39bn | 1.42bn | 1.06bn | 272m | 300m |
| Research and development | 46m | 53m | 57m | 182m | 156m | 174m |
| Selling, general and administrative | 97m | 105m | 103m | 105m | 77m | 75m |
| Operating expenses | 3.45bn | 2.01bn | 2.06bn | 1.81bn | 737m | 745m |
| Operating income | 1.15bn | 1.32bn | 1.04bn | 1.08bn | 189m | 363m |
| Pre-tax income | 736m | 637m | 591m | 668m | −372m | 444m |
| Income tax | 111m | 87m | 116m | 151m | −78m | 92m |
| Net income | 488m | 429m | 368m | 396m | −347m | 303m |
| Earnings per share | 0.20 | 0.18 | 0.15 | 0.17 | −0.15 | 0.13 |
| Earnings per share, diluted | 0.19 | 0.16 | 0.14 | 0.15 | −0.15 | 0.12 |
| Weighted average shares | 2.46bn | 2.43bn | 2.42bn | 2.40bn | 2.35bn | 2.35bn |
| Weighted average shares, diluted | 2.64bn | 2.64bn | 2.64bn | 2.64bn | 2.35bn | 2.58bn |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.60bn | 2.36bn | 1.88bn | 2.25bn | 3.61bn | 3.61bn | 5.64bn | 4.46bn |
| Receivables | 810m | 918m | 633m |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 763m | — | — | 1.11bn | — | — |
| Depreciation and amortisation | 251m | 218m | 267m | 216m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 673m |
| 640m |
| 364m |
| — |
| — |
| Inventory | 241m | 253m | 227m | 184m | 189m | 171m | — | — |
| Current assets | 3.22bn | 4.04bn | 3.26bn | 3.98bn | 4.89bn | 4.56bn | — | — |
| Total assets | 56.30bn | 53.45bn | 50.08bn | 46.51bn | 45.05bn | 43.49bn | — | — |
| Current liabilities | 3.71bn | 4.34bn | 3.92bn | 2.86bn | 2.82bn | 3.54bn | — | — |
| Short-term debt | 126m | 812m | 856m | 197m | 193m | 190m | — | — |
| Long-term debt | 36.46bn | 33.39bn | 31.74bn | 29.77bn | 29.13bn | 29.09bn | — | — |
| Total liabilities | 43.96bn | 41.45bn | 39.26bn | 36.10bn | 35.13bn | 35.60bn | — | — |
| Equity | 7.23bn | 6.74bn | 5.69bn | 5.27bn | 4.88bn | 2.90bn | — | — |
| 89m |
| 70m |
| Share-based compensation | 12m | — | — | 12m | — | — |
| Capital expenditure | 3.18bn | — | — | 3.47bn | — | — |
| Investing cash flow | −3.00bn | — | — | −3.47bn | — | — |
| Dividends paid | 180m | — | — | 190m | — | — |
| Financing cash flow | 1.86bn | — | — | 1.78bn | — | — |